Synergistic neurochemical and behavioural effects of acute intrahippocampal injection of brain-derived neurotrophic factor and antidepressants in adult mice

International Journal of Neuropsychopharmacology

Volumn 12, Issue 7, 2009, Pages 905-915

  Deltheil, Thierry ^a   Tanaka, Kenji ^b   Reperant, Christelle ^a   Hen, René ^b   David, Denis J ^a,b   Gardier, Alain M ^a  

^a University of Paris XI   (France)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

5 HT; Antidepressants; BDNF; Behaviour; Microdialysis

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CITALOPRAM; PAROXETINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BEHAVIOR CHANGE; CONTROLLED STUDY; DEPRESSION; DORSAL RAPHE NUCLEUS; DRUG EFFECT; DRUG POTENTIATION; HIPPOCAMPUS; MALE; MICRODIALYSIS; MOUSE; NEUROCHEMISTRY; NEUROTRANSMISSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROTONINERGIC SYSTEM; TRANQUILIZING ACTIVITY;

ANALYSIS OF VARIANCE; ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; CITALOPRAM; DEPRESSION; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; HIPPOCAMPUS; IN SITU HYBRIDIZATION; MALE; MICE; MICRODIALYSIS; MICROINJECTIONS; MOTOR ACTIVITY; PAROXETINE; RECEPTOR, TRKB; RNA, MESSENGER; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 69749091760     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145709000017     Document Type: Article

References (36)

1. Altar CA (1999). Neurotrophins and depression. Trends in Pharmacological Science 2, 59-61.
2. Bannerman DM, Matthews P, Deacon RM, Rawlins JN (2004). Medial septal lesions mimic effects of both selective dorsal and ventral hippocampal lesions. Behavioral Neuroscience 5, 1033-1041.
3. Benmansour S, Deltheil T, Piotrowski J, Nicolas L, Reperant C, Gardier AM, Frazer A, David DJ (2008). Influence of brain-derived neurotrophic factor (BDNF) on serotonin neurotransmission in the hippocampus of adult rodents. European Journal of Pharmacology 1-3, 90-98.
4. Bert L, Favale D, Jego G, Greve P, Guilloux JP, Guiard BP, Gardier AM, Suaud-Chagny MF, Lestage P (2004). Rapid and precise method to locate microdialysis probe implantation in the rodent brain. Journal of Neuroscience Methods 1-2, 53-57.
5. Calabrese F, Molteni R, Maj PF, Cattaneo A, Gennarelli M, Racagni G, Riva MA (2007). Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. Neuropsychopharmacology 11, 2351-2359.
6. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, Young LT (2001). Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biological Psychiatry 50, 260-265.
7. Crawley JN (1999). Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Research 1, 18-26.
8. David DJ, Bourin M, Jego G, Przybylski C, Jolliet P, Gardier AM (2003). Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice. British Journal of Pharmacology 6, 1128-1136.
9. Daws LC, Munn JL, Valdez MF, Frosto-Burke T, Hensler JG (2007). Serotonin transporter function, but not expression, is dependent on brain-derived neurotrophic factor (BDNF): in vivo studies in BDNF-deficient mice. Journal of Neurochemistry 3, 641-651.
10. Detke MJ, Rickels M, Lucki I (1995). Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berlin) 1, 66-72.
11. Dulawa SC, Holick KA, Gundersen B, Hen R (2004). Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 7, 1321-1330.
12. Duman RS, Heninger GR, Nestler EJ (1997). A molecular and cellular theory of depression. Archives of General Psychiatry 7, 597-606.
13. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN (2003). Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Archives of General Psychiatry 8, 804-815.
14. El Mansari M, Sanchez C, Chouvet G, Renaud B, Haddjeri N (2005). Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electro-physiological study in rat brain. Neuropsychopharmacology 7, 1269-1277.
15. Gobbi G, Blier P (2005). Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: comparison with antidepressant drugs. Peptides 8, 1383-1393.
16. Goggi J, Pullar IA, Carney SL, Bradford HF (2002). Modulation of neurotransmitter release induced by brain-derived neurotrophic factor in rat brain striatal slices in vitro. Brain Research 1-2, 34-42.
17. Govindarajan A, Rao BS, Nair D, Trinh M, Mawjee N, Tonegawa S, Chattarji S (2006). Transgenic brain-derived neurotrophic factor expression causes both anxiogenic and antidepressant effects. Proceedings of the National Academy of Sciences USA 35, 13208-13213.
18. Guiard BP, David DJ, Deltheil T, Chenu F, Le Maitre E, Renoir T, Leroux-Nicollet I, Sokoloff P, Lanfumey L, Hamon M, et al. (2008). Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype. International Journal of Neuropsychopharmacology 1, 79-92.
19. Guilloux JP, David DJ, Guiard BP, Chenu F, Reperant C, Toth M, Bourin M, Gardier AM (2006). Blockade of 5-HT1A receptors by (¡)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice. Neuropsychopharmacology 10, 2162-2172.
20. Hascoet M, Bourin M, Colombel MC, Fiocco AJ, Baker GB (2000). Anxiolytic-like effects of antidepressants after acute administration in a four-plate test in mice. Pharmacology Biochemistry Behavior 2, 339-344.
21. Holick KA, Lee DC, Hen R, Dulawa SC (2008). Behavioral effects of chronic fluoxetine in BALB/cJ mice do not require adult hippocampal neurogenesis or the serotonin 1A receptor. Neuropsychopharmacology 2, 406-417.
22. Hoshaw BA, Malberg JE, Lucki I (2005). Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Research 1-2, 204-208.
23. Leonardo ED, Hen R (2006). Genetics of affective and anxiety disorders. Annual Review of Psychology 57, 117-137.
24. Ma J, Tanaka KF, Yamada G, Ikenaka K (2007). Induced expression of cathepsins and cystatin C in a murine model of demyelination. Neurochemistry Research 2, 311-320.
25. Madhav TR, Pei Q, Zetterstrom TS (2001). Serotonergic cells of the rat raphe nuclei express mRNA of tyrosine kinase B (trkB), the high-affinity receptor for brain derived neurotrophic factor (BDNF). Brain Research Molecular Brain Research 1, 56-63.
26. Martinowich K, Lu B (2008). Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 1, 73-83.
27. Nibuya M, Morinobu S, Duman RS (1995). Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Journal of Neuroscience 11, 7539-7547.
28. Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I (1999). Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology (Berlin) 2, 162-167.
29. Patapoutian A, Reichardt LF (2001). Trk receptors: mediators of neurotrophin action. Current Opinion Neurobiology 3, 272-280.
30. Paxinos G, Franklin KBJ (2001). The Mouse Brain in Stereotaxic Coordinates, 2nd edn. New York: Academic Press.
31. Rantamaki T, Hendolin P, Kankaanpaa A, Mijatovic J, Piepponen P, Domenici Ez, Chao MV, Mannisto PT, Castren E (2007). Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacology 10, 2152-2162.
32. Romero L, Artigas F (1997). Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors. Journal of Neurochemistry 6, 2593-2603.
33. Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, MacDonald E, Agerman K, Haapasalo A, Nawa H, Aloyz R, Ernfors P, Castren E (2003). Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. Journal of Neuroscience 1, 349-357.
34. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS (2002). Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. Journal of Neuroscience 8, 3251-3261.
35. Sommerfeld MT, Schweigreiter R, Barde YA, Hoppe E (2000). Down-regulation of the neurotrophin receptor TrkB following ligand binding. Evidence for an involvement of he proteasome and differential regulation of TrkA and TrkB. Journal of Biological Chemistry 12, 8982-8990.
36. Wyneken U, Sandoval M, Sandoval S, Jorquera F, González I, Vargas F, Falcon R, Monari M, Orrego F (2006). Clinically relevant doses of fluoxetine and reboxetine induce changes in the TrkB content of central excitatory synapses. Neuropsychopharmacology 31, 2415-23.